Читать книгу The Future of Health - Roberto Ascione - Страница 11

Empatica Inc., a spin-off of MIT's Media Lab, with offices in Cambridge and Milan, has built a smartwatch based on an advanced machine learning algorithm. It is capable of identifying seizures and sending alerts to the caregivers, recording sleep and rest data, and detecting electrodermal activity (EDA). EDA allows researchers to quantify physiological changes in the sympathetic nervous system, also known as the fight-or-flight response. It is the first device linked to a neurological condition that has been approved by the FDA.

Certified in Europe and the United States, Empatica's Embrace 2 is a device for adults and children over the age of 6. In a multisite clinical trial, 135 patients diagnosed with epilepsy were admitted to high-level monitoring units for continuous monitoring of level IV epilepsy. There, video electroencephalography (EEG) was used to monitor their brain activity. Simultaneously, they wore an Empatica device. In 272 days, 6,530 hours of data were recorded, including 40 generalized tonic-clonic seizures. Embrace's algorithm has been shown to detect 100 percent of the seizures.